LUNG

Pulmonx Corporation

Price

$2.44

return (12m)

38.35%

p/e

-1.99

p/bv

2.44

DIVIDEND YIELD

0.00%

LUNG price

Pulmonx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LUNG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

47.13%

3 months

47.58%

1 year

38.35%

2 years

-67.36%

5 years

-93.93%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LUNG

Valuation

P/E

-1.99

Sector -0.16

Industry 2.77

P/BV

2.44

Sector 1.93

Industry 2.37

P/Revenue (PSR)

1.10

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

0.83

Sector 0.91

Industry 1.07

P/Net Current Assets

7.61

Sector -24.70

Industry -5.25

P/Working Capital

1.41

Sector -5.32

Industry 3.11

EPS

-1.15

Sector -0.79

Industry -0.61

BVPS

0.93

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

77.04%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-52.96%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-55.03%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.20

Sector 0.13

Industry 0.15

Profitability

ROE

-122.76%

Sector -31.93%

Industry -27.86%

ROA

-41.94%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.32

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

0.95

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.95

Sector -0.72

Industry 0.10

Equity/Assets

0.34

Sector 0.43

Industry 0.45

Liabilities/Assets

0.66

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

12.56%

Sector -

Industry -

5Y Earnings CAGR

-0.22%

Sector -

Industry -

Fundamentals LUNG

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LUNG Pulmonx Corporation	$2.44	30.91%	0.00%	-1.99	2.44	-122.76%	-55.03%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%
INMD InMode Ltd.	$14.84	-2.34%	0.00%	11.50	1.42	12.32%	20.69%
DXCM DexCom Inc.	$90.49	18.47%	0.00%	34.80	13.27	38.14%	20.12%
EW Edwards Lifesciences Corp.	$90.23	11.53%	0.00%	51.94	4.86	9.36%	15.41%
BDX Becton Dickinson and Company	$189.33	-0.19%	2.21%	55.38	2.14	3.86%	6.30%
ALGN Align Technology Inc.	$157.75	11.11%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.75	20.18%	1.42%	49.15	11.14	22.66%	26.71%
SNN Smith & Nephew PLC	$28.91	-19.76%	2.63%	11.09	2.41	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LUNG Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Pulmonx

Pulmonx Corporation

Average Investor10 user rating

4.0 (0 people)

United States

31 years

Founded: 1995

2020

Time since IPO - 6 years

170

Employees

Pulmonx Corporation (United States) is listed on the Nasdaq and has a market capitalization of $95.76 million, with shareholders equity totaling $39.20 million.

The company employs approximately 170 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Pulmonx Corporation reported $87.45 million in revenue, generating net income of $-48.12 million.

Key financial metrics include a P/E ratio of -1.99, a price-to-book (P/B) ratio of 2.44, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LUNG.

Market cap

$95.76 million

Net worth

$39.20 million

$39,200,000.00

Assets

$114.73 million

$114,730,000.00

Total Shares Outstanding

42.00 million

42,000,000

Average Daily Trading Volume

$647.16 Thousand

$647,159.82

Sector

Health

Industry

Medical Supplies and Equipment

LUNG

LUNG revenue and profits

Financial Results LUNG

DRAG THE FRAME TO SEE MORE DATA

LUNG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75